{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:12:58Z","timestamp":1750479178043},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,26]]},"DOI":"10.7759\/cureus.11164","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T07:03:31Z","timestamp":1603695811000},"source":"Crossref","is-referenced-by-count":2,"title":["A Curious Case of Colonic Perivascular Epithelioid Cell Tumor: A Unique Diagnosis With Variable Presentations"],"prefix":"10.7759","author":[{"given":"Joseph","family":"Bennett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquele","family":"Laury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup","family":"Kasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Walde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199203000-00013","article-title":"PEC and sugar","volume":"16","author":"Bonetti F","year":"1992","unstructured":"Bonetti F, Pea M, Martignoni G, Zamboni G. PEC and sugar. Am J Surg Pathol. 1992, 16:307-8. 10.1097\/00000478-199203000-00013","journal-title":"Am J Surg Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqz040","article-title":"Gastric perivascular epithelioid cell tumor (PEComa)","volume":"5","author":"Xu J","year":"2019","unstructured":"Xu J, Yan Y, Xiang X, Jiang P, Hu X, Yang W. Gastric perivascular epithelioid cell tumor (PEComa). Am J Clin Pathol. 2019, 5:221-229. 10.1093\/ajcp\/aqz040","journal-title":"Am J Clin Pathol"},{"key":"ref3","article-title":"World Health Organization Classification Tumors of Soft Tissue and Bone Vol 5","author":"Fletcher CDM","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. World Health Organization Classification Tumors of Soft Tissue and Bone Vol 5. Fletcher CDM (ed): IARC, 2013."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"A distinctive subset of PEComas harbors TFE3 gene fusions","volume":"34","author":"Argani P","year":"2010","unstructured":"Argani P, Aulmann S, Illei PB, et al.. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol. 2010, 34:1395-406. 10.1097\/PAS.0b013e3181f17ac0","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0385-RS","article-title":"Alveolar soft part sarcoma","volume":"139","author":"Jaber OI","year":"2015","unstructured":"Jaber OI, Kirby PA. Alveolar soft part sarcoma. Arch Pathol Lab Med. 2015, 139:1459-62. 10.5858\/arpa.2014-0385-RS","journal-title":"Arch Pathol Lab Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-015-0399-5","article-title":"Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression","volume":"15","author":"Zhao M","year":"2015","unstructured":"Zhao M, Rao Q, Wu C, Zhao Z, He X, Ru G. Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression. Diagn Pathol. 2015, 15:160. 10.1186\/s13000-015-0399-5","journal-title":"Diagn Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318031ffff","article-title":"Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum","volume":"31","author":"Argani P","year":"2007","unstructured":"Argani P, Olgac S, Tickoo SK, et al.. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007, 31:1149-60. 10.1097\/PAS.0b013e318031ffff","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani P","year":"2001","unstructured":"Argani P, Antonescu CR, Illei PB, et al.. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001, 159:179-92. 10.1016\/s0002-9440(10)61684-7","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31829caab3","article-title":"PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters","volume":"37","author":"Doyle LA","year":"2013","unstructured":"Doyle LA, Hornick JL, Fletcher CD. PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2013, 37:1769-82. 10.1097\/PAS.0b013e31829caab3","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/541626","article-title":"\"Malignant\" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies","volume":"2012","author":"Bleeker JS","year":"2012","unstructured":"Bleeker JS, Quevedo JF, Folpe AL. \"Malignant\" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma. 2012, 2012:541626. 10.1155\/2012\/541626","journal-title":"Sarcoma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165-133.4.648","article-title":"Perivascular epithelioid cell tumor","volume":"133","author":"Armah HB","year":"2009","unstructured":"Armah HB, Parwani AV. Perivascular epithelioid cell tumor. Arch Pathol Lab Med. 2009, 133:648-54. 10.1043\/1543-2165-133.4.648","journal-title":"Arch Pathol Lab Med"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.27800","article-title":"Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates","volume":"132","author":"Dickson MA","year":"2013","unstructured":"Dickson MA, Schwartz GK, Antonescu CR, Kwiatkowski DJ, Malinowska IA. Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates. Int J Cancer. 2013, 132:1711-7.","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.25.2981","article-title":"Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors","volume":"28","author":"Wagner AJ","year":"2010","unstructured":"Wagner AJ, Malinowska-Kolodziej I, Morgan JA, et al.. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol. 2010, 28:835-40. 10.1200\/jco.2009.25.2981","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler JJ","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR, et al.. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008, 358:140-51. 10.1056\/NEJMoa063564","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-19-0288","article-title":"Role of chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in advanced perivascular epithelioid cell tumors (PEComas)","volume":"25","author":"Sanfilippo R","year":"2019","unstructured":"Sanfilippo R, Jones RL, Blay JY, et al.. Role of chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in advanced perivascular epithelioid cell tumors (PEComas). Clin Cancer Res. 2019, 25:5295-5300. 10.1158\/1078-0432.Ccr-19-0288","journal-title":"Clin Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37171-a-curious-case-of-colonic-perivascular-epithelioid-cell-tumor-a-unique-diagnosis-with-variable-presentations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:42Z","timestamp":1707506382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37171-a-curious-case-of-colonic-perivascular-epithelioid-cell-tumor-a-unique-diagnosis-with-variable-presentations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.11164","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,26]]}}}